{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:39:28Z","timestamp":1790278768735,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Anxiety Disorders"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.janxdis.2019.102151","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T10:07:44Z","timestamp":1572689264000},"page":"102151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Cost-Effectiveness of Treatment Alternatives for Treatment-Refractory Pediatric Obsessive-Compulsive Disorder"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3157-0316","authenticated-orcid":false,"given":"Sean T.","family":"Gregory","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley C.","family":"Riemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne K.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Storch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.janxdis.2019.102151_bib0005","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1037\/0022-006X.71.2.394","article-title":"Exposure and ritual prevention for obsessive-compulsive disorder: effects of intensive versus twice-weekly sessions","volume":"71","author":"Abramowitz","year":"2003","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"10.1016\/j.janxdis.2019.102151_bib0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00004583-200401000-00014","article-title":"Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial","volume":"43","author":"Barrett","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"8","key":"10.1016\/j.janxdis.2019.102151_bib0015","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/da.22103","article-title":"Long-term outcome in adults with obsessive-compulsive disorder","volume":"30","author":"Bloch","year":"2013","journal-title":"Depress Anxiety"},{"issue":"4","key":"10.1016\/j.janxdis.2019.102151_bib0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaac.2015.01.011","article-title":"Assessment and management of treatment-refractory obsessive-compulsive disorder in children","volume":"54","author":"Bloch","year":"2015","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.janxdis.2019.102151_bib0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jbtep.2006.11.002","article-title":"Evaluation of exposure with response-prevention for obsessive compulsive disorder in childhood and adolescence","volume":"39","author":"Bolton","year":"2008","journal-title":"J Behav Ther Exp Psychiatry"},{"issue":"1","key":"10.1016\/j.janxdis.2019.102151_bib0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00004583-199201000-00008","article-title":"Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial","volume":"31","author":"DeVeaugh-Geiss","year":"1992","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.janxdis.2019.102151_bib0035","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"2005"},{"issue":"1","key":"10.1016\/j.janxdis.2019.102151_bib0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1176\/appi.ajp.162.1.151","article-title":"Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder","volume":"162","author":"Foa","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.1016\/j.janxdis.2019.102151_bib0045","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.2011.1344","article-title":"Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial","volume":"306","author":"Franklin","year":"2011","journal-title":"Jama"},{"issue":"6","key":"10.1016\/j.janxdis.2019.102151_bib0050","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/jamapsychiatry.2014.170","article-title":"Family-based treatment of early childhood obsessive-compulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children (POTS Jr)--a randomized clinical trial","volume":"71","author":"Freeman","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.janxdis.2019.102151_bib0055","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/jamapsychiatry.2014.170","article-title":"Family-based treatment of early childhood obsessive-compulsive disorder: the pediatric obsessive-compulsive disorder treatment study for young children (POTS Jr)-a randomized clinical trial","author":"Freeman","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.janxdis.2019.102151_bib0060","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/CHI.0b013e31816765f9","article-title":"Early childhood OCD: preliminary findings from a family-based cognitive-behavioral approach","volume":"47","author":"Freeman","year":"2008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.janxdis.2019.102151_bib0065","series-title":"Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder","first-page":"1919","author":"Geller","year":"2003"},{"issue":"7","key":"10.1016\/j.janxdis.2019.102151_bib0070","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00004583-200107000-00011","article-title":"Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial","volume":"40","author":"Geller","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.janxdis.2019.102151_bib0075","first-page":"98","article-title":"Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder","volume":"51","author":"Geller","year":"2012","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"11","key":"10.1016\/j.janxdis.2019.102151_bib0080","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/01.chi.0000138356.29099.f1","article-title":"Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial","volume":"43","author":"Geller","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.janxdis.2019.102151_bib0085","series-title":"Cost-Effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"issue":"2","key":"10.1016\/j.janxdis.2019.102151_bib0090","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11552","article-title":"Treatment-Refractory Obsessive-Compulsive Disorder in Adults: A Cost-Effectiveness Analysis of Treatment Strategies","volume":"79","author":"Gregory","year":"2018","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"10.1016\/j.janxdis.2019.102151_bib0095","first-page":"292","article-title":"Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients","volume":"51","author":"Greist","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.janxdis.2019.102151_bib0100","series-title":"Decision making in health and medicine : integrating evidence and values","author":"Hunink","year":"2014"},{"issue":"2","key":"10.1016\/j.janxdis.2019.102151_bib0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force","volume":"16","author":"Husereau","year":"2013","journal-title":"VALUE IN HEALTH"},{"key":"10.1016\/j.janxdis.2019.102151_bib0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","article-title":"ISPOR Task Force Report: Consolidated Health Economic Evaluation Reporting Standards (CHEERS)\u2014Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force","volume":"16","author":"Husereau","year":"2013","journal-title":"Value in Health"},{"issue":"1","key":"10.1016\/j.janxdis.2019.102151_bib0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.psychres.2015.01.015","article-title":"The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: Views based on a systematic review and meta-analysis","volume":"227","author":"Ivarsson","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.janxdis.2019.102151_bib0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.genhosppsych.2016.06.001","article-title":"Outcome of multidisciplinary, CBT-focused treatment for pediatric OCD","volume":"42","author":"Kay","year":"2016","journal-title":"General Hospital Psychiatry"},{"issue":"11","key":"10.1016\/j.janxdis.2019.102151_bib0125","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00127-009-0013-9","article-title":"Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent-child agreement, and clinical correlates","volume":"44","author":"Lack","year":"2009","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"1","key":"10.1016\/j.janxdis.2019.102151_bib0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1586\/14737175.2016.1126181","article-title":"Family accommodation in obsessive-compulsive and anxiety disorders: a five-year update","volume":"16","author":"Lebowitz","year":"2016","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.janxdis.2019.102151_bib0135","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.psychres.2010.08.021","article-title":"Refining clinical judgment of treatment outcome in obsessive-compulsive disorder","volume":"185","author":"Lewin","year":"2011","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.janxdis.2019.102151_bib0140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brat.2014.02.001","article-title":"Family-based exposure and response prevention therapy for preschool-aged children with obsessive-compulsive disorder: a pilot randomized controlled trial","volume":"56","author":"Lewin","year":"2014","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.janxdis.2019.102151_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.psc.2014.05.002","article-title":"Cognitive Behavior Therapy for Obsessive-Compulsive and Related Disorders","author":"Lewin","year":"2014","journal-title":"Psychiatric Clinics of North America"},{"issue":"12","key":"10.1016\/j.janxdis.2019.102151_bib0150","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/00004583-200212000-00014","article-title":"Fluoxetine in children and adolescents with OCD: a placebo-controlled trial","volume":"41","author":"Liebowitz","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"20","key":"10.1016\/j.janxdis.2019.102151_bib0155","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/jama.280.20.1752","article-title":"Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial","volume":"280","author":"March","year":"1998","journal-title":"Jama"},{"issue":"8","key":"10.1016\/j.janxdis.2019.102151_bib0160","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/da.22389","article-title":"A Meta-Analysis of Cognitive Behavior Therapy and Medication for Child Obsessive Compulsive Disorder: Moderators of Treatment Efficacy, Response, and Remission","volume":"32","author":"McGuire","year":"2015","journal-title":"Depression and anxiety"},{"issue":"24","key":"10.1016\/j.janxdis.2019.102151_bib0165","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2018.6072","article-title":"Qalys in 2018\u2014advantages and concerns","volume":"319","author":"Neumann","year":"2018","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.janxdis.2019.102151_bib0170","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1001\/jama.292.16.1969","article-title":"Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial","volume":"292","author":"Pediatric OCD Treatment Study (POTS) Team","year":"2004","journal-title":"Jama"},{"issue":"11","key":"10.1016\/j.janxdis.2019.102151_bib0175","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jaac.2011.08.003","article-title":"Controlled comparison of family cognitive behavioral therapy and psychoeducation\/relaxation training for child obsessive-compulsive disorder","volume":"50","author":"Piacentini","year":"2011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.janxdis.2019.102151_bib0180","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00004583-200102000-00017","article-title":"Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial","volume":"40","author":"Riddle","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"10.1016\/j.janxdis.2019.102151_bib0185","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/00004583-199211000-00011","article-title":"Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder","volume":"31","author":"Riddle","year":"1992","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"8","key":"10.1016\/j.janxdis.2019.102151_bib0190","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/da.22232","article-title":"BEHAVIORAL THERAPY AND SEROTONIN REUPTAKE INHIBITOR PHARMACOTHERAPY IN THE TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF HEAD-TO-HEAD RANDOMIZED CONTROLLED TRIALS","author":"Romanelli","year":"2014","journal-title":"Depression and Anxiety"},{"issue":"5","key":"10.1016\/j.janxdis.2019.102151_bib0195","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1176\/appi.ajp.2007.07091440","article-title":"A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder","volume":"165","author":"Simpson","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.janxdis.2019.102151_bib0200","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00787-014-0613-0","article-title":"Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial","volume":"24","author":"Skarphedinsson","year":"2015","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.janxdis.2019.102151_bib0205","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00787-014-0613-0","article-title":"Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive\u2013compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial","volume":"24","author":"Skarphedinsson","year":"2015","journal-title":"European Child & Adolescent Psychiatry"},{"issue":"8","key":"10.1016\/j.janxdis.2019.102151_bib0210","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0005-7967(96)00036-8","article-title":"The Yale-Brown Obsessive Compulsive Scale: interview versus self-report","volume":"34","author":"Steketee","year":"1996","journal-title":"Behav Res Ther"},{"issue":"1","key":"10.1016\/j.janxdis.2019.102151_bib0215","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.2004.00302.x","article-title":"Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature","volume":"110","author":"Stewart","year":"2004","journal-title":"Acta Psychiatr Scand"},{"issue":"12","key":"10.1016\/j.janxdis.2019.102151_bib0220","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.brat.2013.09.007","article-title":"Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder","volume":"51","author":"Storch","year":"2013","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.janxdis.2019.102151_bib0225","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.brat.2013.09.007","article-title":"Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive\u2013compulsive disorder","volume":"51","author":"Storch","year":"2013","journal-title":"Behaviour Research and Therapy"},{"issue":"4","key":"10.1016\/j.janxdis.2019.102151_bib0230","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/chi.0b013e31803062e7","article-title":"Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches","volume":"46","author":"Storch","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.janxdis.2019.102151_bib0235","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.janxdis.2009.12.004","article-title":"Predictors of functional impairment in pediatric obsessive-compulsive disorder","volume":"24","author":"Storch","year":"2010","journal-title":"Journal of Anxiety Disorders"},{"issue":"2","key":"10.1016\/j.janxdis.2019.102151_bib0240","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/15374410903532676","article-title":"An open trial of intensive family based cognitive-behavioral therapy in youth with obsessive-compulsive disorder who are medication partial responders or nonresponders","volume":"39","author":"Storch","year":"2010","journal-title":"J Clin Child Adolesc Psychol"},{"key":"10.1016\/j.janxdis.2019.102151_bib0245","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brat.2014.11.005","article-title":"Effectiveness of cognitive behavior treatment for pediatric obsessive-compulsive disorder: acute outcomes from the Nordic Long-term OCD Treatment Study (NordLOTS)","volume":"64","author":"Torp","year":"2015","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.janxdis.2019.102151_bib0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaac.2016.07.768","article-title":"New research: Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder","author":"Varigonda","year":"2016","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.janxdis.2019.102151_bib0255","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1111\/j.1524-4733.2009.00515.x","article-title":"QALYs: the basics","volume":"12","author":"Weinstein","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.janxdis.2019.102151_bib0260","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldq033","article-title":"Health outcomes in economic evaluation: the QALY and utilities","volume":"96","author":"Whitehead","year":"2010","journal-title":"Br Med Bull"},{"key":"10.1016\/j.janxdis.2019.102151_bib0265","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2015-308255","article-title":"QALYs in cost-effectiveness analysis: an overview for cardiologists","author":"Wouters","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.janxdis.2019.102151_bib0270","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cpr.2016.03.003","article-title":"A meta-analysis of family accommodation and OCD symptom severity","volume":"45","author":"Wu","year":"2016","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/j.janxdis.2019.102151_bib0275","doi-asserted-by":"crossref","DOI":"10.1016\/S1056-4993(18)30163-9","article-title":"The epidemiology of obsessive-compulsive disorder in children and adolescents","author":"Zohar","year":"1999","journal-title":"Child and Adolescent Psychiatric Clinics of North America"}],"container-title":["Journal of Anxiety Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887618518302792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887618518302792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:11:27Z","timestamp":1760137887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887618518302792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":55,"alternative-id":["S0887618518302792"],"URL":"https:\/\/doi.org\/10.1016\/j.janxdis.2019.102151","relation":{},"ISSN":["0887-6185"],"issn-type":[{"value":"0887-6185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Treatment Alternatives for Treatment-Refractory Pediatric Obsessive-Compulsive Disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Anxiety Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.janxdis.2019.102151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102151"}}